Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bionomics initiates enrollment in clinical phase I/II trial of BNC-105 in renal cell carcinoma

Jan. 28, 2010

New protein kinase inhibitors for the treatment of cancer discovered at Plexxikon

Jan. 27, 2010

PI3K and mTOR inhibitors in early development at Wyeth

Jan. 27, 2010

Preclinical activity of novel mitotic kinesin inhibitor supports clinical evaluation in cancer

Jan. 27, 2010

Schering Plough receives approval for Temodal in Japan

Jan. 27, 2010

Spectrum meets with FDA regarding Fusilev sNDA for colorectal cancer

Jan. 26, 2010

Merck KGaA claims tyrosine kinase inhibitors for the treatment of cancer

Jan. 26, 2010

Clinical data show safety and efficacy of dasatinib as initial therapy for CML

Jan. 26, 2010

Clinical data shows nilotinib to be an effective front-line treatment for CML

Jan. 26, 2010

OVATURE trial analysis to proceed following database lock

Jan. 25, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...